Asplin J - Search Results

1

Urine and stone analysis for the investigation of the renal stone former: a consensus conference.

Williams JC Jr, Gambaro G, Rodgers A, Asplin J, Bonny O, Costa-Bauzá A, Ferraro PM, Fogazzi G, Fuster DG, Goldfarb DS, Grases F, Heilberg IP, Kok D, Letavernier E, Lippi G, Marangella M, Nouvenne A, Petrarulo M, Siener R, Tiselius HG, Traxer O, Trinchieri A, Croppi E, Robertson WG. Williams JC Jr, et al. Among authors: asplin j. Urolithiasis. 2021 Feb;49(1):1-16. doi: 10.1007/s00240-020-01217-3. Epub 2020 Oct 13. Urolithiasis. 2021. PMID: 33048172 Free PMC article.

2

Supersaturation and stone composition in a network of dispersed treatment sites.

Asplin J, Parks J, Lingeman J, Kahnoski R, Mardis H, Lacey S, Goldfarb D, Grasso M, Coe F. Asplin J, et al. J Urol. 1998 Jun;159(6):1821-5. doi: 10.1016/S0022-5347(01)63164-1. J Urol. 1998. PMID: 9598467

3

Medical reduction of stone risk in a network of treatment centers compared to a research clinic.

Lingeman J, Mardis H, Kahnoski R, Goldfarb DS, Lacy S, Grasso M, Scheinman SJ, Parks JH, Asplin JR, Coe FL. Lingeman J, et al. Among authors: asplin jr. J Urol. 1998 Nov;160(5):1629-34. J Urol. 1998. PMID: 9783920 Free article.

4

Divergence between stone composition and urine supersaturation: clinical and laboratory implications.

Lingeman J, Kahnoski R, Mardis H, Goldfarb DS, Grasso M, Lacy S, Scheinman SJ, Asplin JR, Parks JH, Coe FL. Lingeman J, et al. Among authors: asplin jr. J Urol. 1999 Apr;161(4):1077-81. J Urol. 1999. PMID: 10081841

5

Clinical use of cystine supersaturation measurements.

Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL. Nakagawa Y, et al. Among authors: asplin jr. J Urol. 2000 Nov;164(5):1481-5. J Urol. 2000. PMID: 11025687

6

Effect of grapefruit juice on urinary lithogenicity.

Goldfarb DS, Asplin JR. Goldfarb DS, et al. Among authors: asplin jr. J Urol. 2001 Jul;166(1):263-7. J Urol. 2001. PMID: 11435883 Clinical Trial.

7

Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria.

Dolin DJ, Asplin JR, Flagel L, Grasso M, Goldfarb DS. Dolin DJ, et al. Among authors: asplin jr. J Endourol. 2005 Apr;19(3):429-32. doi: 10.1089/end.2005.19.429. J Endourol. 2005. PMID: 15865542

8

Urinary cystine excretion and capacity in patients with cystinuria.

Goldfarb DS, Coe FL, Asplin JR. Goldfarb DS, et al. Among authors: asplin jr. Kidney Int. 2006 Mar;69(6):1041-7. doi: 10.1038/sj.ki.5000104. Kidney Int. 2006. PMID: 16501494 Free article.

9

Chitosan does not reduce post-prandial urinary oxalate excretion.

Wolf J, Asplin JR, Goldfarb DS. Wolf J, et al. Among authors: asplin jr. Urol Res. 2006 Aug;34(4):227-30. doi: 10.1007/s00240-006-0048-2. Epub 2006 Feb 28. Urol Res. 2006. PMID: 16506035 Clinical Trial.

10

A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria.

Goldfarb DS, Modersitzki F, Asplin JR. Goldfarb DS, et al. Clin J Am Soc Nephrol. 2007 Jul;2(4):745-9. doi: 10.2215/CJN.00600207. Epub 2007 May 30. Clin J Am Soc Nephrol. 2007. PMID: 17699491 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page